🚨ARION PRODIGE 67🚨 Locally Advanced Esophagus Cancer (adeno or squam) n=112 Randomized CRT (50 Gy/25 Fx + FOLFOX) +/- concurrent and adjuvant durvalumab (total 12 m) No SS differences in: PFS 48% vs. 50% OS 68% vs. 75% #ESMO26 https://t.co/yDHzaOsCyB